These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10575280)

  • 1. [Does the study "Complementary medicine in health insurance" provide a basis for scientifically valid conclusions?].
    Kienle GS; Kiene H
    Forsch Komplementarmed; 1999 Oct; 6(5):262-70. PubMed ID: 10575280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health economic analysis of the effects of including complementary medicine in the benefit package of health insurance].
    Sommer JH
    Forsch Komplementarmed; 1999 Feb; 6 Suppl 1():7-9. PubMed ID: 10077706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health economic analysis of the effects of offered complementary medical procedures on health insurance].
    Sommer JH; Bürgi M
    Schweiz Med Wochenschr Suppl; 1994; 62():13-7. PubMed ID: 8073235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of costs for complementary medicine after provisional inclusion into the Swiss basic health insurance.
    Studer HP; Busato A
    Forsch Komplementmed; 2011; 18(1):15-23. PubMed ID: 21372583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized experiment of the effects of including alternative medicine in the mandatory benefit package of health insurance funds in Switzerland.
    Sommer JH; Bürgi M; Theiss R
    Complement Ther Med; 1999 Jun; 7(2):54-61. PubMed ID: 10444908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Swiss basic health insurance costs of complementary and conventional medicine.
    Studer HP; Busato A
    Forsch Komplementmed; 2011; 18(6):315-20. PubMed ID: 22189362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on Sommer et al. 'A randomized experiment of the effects of including alternative medicine in the mandatory benefit package of health insurance.
    Heusser P
    Complement Ther Med; 2000 Mar; 8(1):50-3. PubMed ID: 10812762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent and structure of health insurance expenditures for complementary and alternative medicine in Swiss primary care.
    Busato A; Eichenberger R; Künzi B
    BMC Health Serv Res; 2006 Oct; 6():132. PubMed ID: 17032465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complementary medicine in health insurance. Economic analysis of the effects of including complementary procedures in health insurance. Project within the scope of the "Complementary Medicine" Research Program 34].
    Sommer JH; Bürgi M; Theiss R
    Schweiz Med Wochenschr Suppl; 1998; 102():1S-129S. PubMed ID: 9782552
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complementary medicine--health policy and health care costs].
    Jungi WF
    Praxis (Bern 1994); 1997 Oct; 86(41):1593-7. PubMed ID: 9417579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic evaluation in complementary medicine: development within the last decades concerning local origin and quality.
    Ostermann T; Krummenauer F; Heusser P; Boehm K
    Complement Ther Med; 2011 Dec; 19(6):289-302. PubMed ID: 22036521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of unconventional medical therapies by the Medical Review Board of the Statutory Health Insurance Funds (MDK)].
    Windeler J; Burkhard B
    Z Arztl Fortbild Qualitatssich; 2004 Sep; 98(6):477-80. PubMed ID: 15527190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Motivation for the choice of complementary and mainstream medicine. Patients' behavior in a pluralistic medical system].
    Schär A; Messerli-Rohrbach V
    Forsch Komplementarmed; 1999 Feb; 6 Suppl 1():10-3. PubMed ID: 10077707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk selection and complementary health insurance: the Swiss approach.
    Kifmann M
    Int J Health Care Finance Econ; 2006 Jun; 6(2):151-70. PubMed ID: 16783507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complementary medicine and health legislation].
    Künzi M
    Forsch Komplementarmed; 1999 Feb; 6 Suppl 1():14-6. PubMed ID: 10077708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The springtime of LAMal (Health Insurance)].
    Dreifuss R
    Rev Med Suisse Romande; 1996 Jul; 116(7):549-52. PubMed ID: 8765570
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual choice health insurance policy: a proposal and a cost analysis.
    Cheng J; Ives JC
    J Health Care Finance; 2009; 36(2):60-70. PubMed ID: 20499722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine in asthma--safety, effectiveness and costs.
    Brutsche MH
    Swiss Med Wkly; 2002 Jun; 132(25-26):329-31. PubMed ID: 12422288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.